Skip to main content
SpringerLink
Log in

Mehr Auswahl für die komplette Therapie

Bessere Compliance durch Fixkombinationen und einmal tägliche Gabe

  • FORTBILDUNG
  • ÜBERSICHT
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Da eine Eradikation oder eine Heilung der HIV-Infektion bisher nicht möglich ist, muss die ART lebenslang erfolgen. Voraussetzung für den Therapieerfolg ist eine gute Compliance der Patienten. Fixkombinationen und Single-Tablet-Regime leisten hierzu einen sinnvollen Beitrag.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abbildung 1

Literatur

  1. Aragão F, et al. EACS 2011. Belgrade, Serbia. #PE7.5/5

  2. Bangalore S, et al. Am J Med 2007;120:713–9

    Article  PubMed  Google Scholar 

  3. Cohen MS, et al. N Engl J Med 2011;10.1056

    Google Scholar 

  4. D:A:D Study Group. AIDS 2010;24:1537-1548.

  5. Deutsch-Österreichische Leitlinien zur antiretroviralen Therapie der HIV-1-Infektion. DAIG/ÖAG, März 2010. www.daignet.de/site-content/hiv-therapie/leitlinien-1/Leitlinien_28-05-2010_V_late.pdf

  6. DHHS Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents 2011 [online]. www.aidsinfo.nih.gov/ContentFiles/AdultsandAdolescentGL.pdf (Accessed 25.03.2012)

  7. El-Sadr WM, et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 2006;355(22):2283–96

    Article  PubMed  CAS  Google Scholar 

  8. Guidelines for the clinical management and treatment of HIV infected adults in Europe. European AIDS Clinical Society (EACS); www.europeanaidsclinicalsociety.org/images/stories/EACS-pdf/eacs-euroguidelines_fullversion.pdf

  9. Homar F, et al. EACS 2011. Belgrade, Serbia. #PE9.11/2

  10. Kitahata MM, et al. Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death. Int J STD AIDS 2004;15:803–810

    Article  PubMed  Google Scholar 

  11. Llibre JM, et al. Clinical implications of fixed-dose coformulations (FDACS) on the outcome of HIV-1-therapy. AIDS 2011;25(14):1683–90

    Article  PubMed  Google Scholar 

  12. Reis A, et al. HIV10 2010. Glasgow. Poster #199

  13. Sax P, et al. Adherence to antiretroviral treatment regimens and correlation with risk of hospitalization among commercially insured patients in the US. Journal of the International AIS Society 2010, 13(Suppl 4):O3. www.jiasociety.org/content/13/S4/O3

Download references

Author information

Authors and Affiliations

  1. Klinik für Dermatologie und Venerologie Universitätsklinikum Essen, Hufelandstraße 55, D-45122, Essen, Deutschland

    Stefan Esser

Authors
  1. Stefan Esser
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stefan Esser.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Esser, S. Mehr Auswahl für die komplette Therapie. MMW - Fortschritte der Medizin 154, 17–20 (2012). https://doi.org/10.1007/s15006-012-0620-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-012-0620-3

Keywords - Fixed dose combinations and single tablet regimen for HIV therapy

Search

Navigation